3 Key Things You'll Want to Know About AstraZeneca's COVID-19 Vaccine Results
World Health Organization chief scientist Soumya Swaminathan thinks there's one likely leading candidate in the race to develop a COVID-19 vaccine. That leader is AZD1222, the novel-coronavirus vaccine candidate that's being developed by AstraZeneca (NYSE: AZN) and the University of Oxford.
And the world now knows more about how safe and effective AZD1222 could be. AstraZeneca announced on Monday interim results from an ongoing phase 1/2 clinical study of the experimental COVID-19 vaccine. The interim results were published in The Lancet. Here are three key things you'll want to know about AstraZeneca's news.
Image source: Getty Images.
Source Fool.com
